When psoriatic arthritis symptoms are under control, you may be tempted to stop taking medication. Here’s why that’s a bad idea.

Significant gaps in arthritis subtype awareness among US adults underscore the need for improved health literacy and more ...

PsA can be challenging, but these expert-approved tips for reframing how you think, talk, and feel about your condition can ...

Patients with psoriatic arthritis who meet clinical criteria for minimal disease activity also tend to report good disease ...

This review discusses the features of oligoarticular, polyarticular, systemic, and psoriatic JIA and enthesitis-related ...

Michaela Hagenhofer, General Manager, Commercial Operations at Johnson & Johnson Innovative Medicine, explains how J&J is ...

Discover effective treatments for psoriatic arthritis, with expert tips on managing symptoms, reducing inflammation, and improving joint health for a better quality of life.

Tumor necrosis factor (TNF) inhibitor therapy was effective in reducing the likelihood that psoriasis would progress to ...

Racial and ethnic diversity is lacking in PsA clinical trials, with non-White participants remaining severely underrepresented.

Zentiva Group has entered into a licence and supply agreement with pharmaceutical company Lupin for the commercialisation of ...

The pharma began its outreach to the HS community well before securing Bimzelx’s approval in the indication. In the spring of ...

It is indicated for various diseases including heumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...